POULTON STUART (EVP, Chief Development Officer) sold 5.1% of their position (5.10K shares) of KARYOPHARM THERAPEUTICS INC. on the open market
Open‑market sale worth $48.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2026ACC: 0001942597-26-000003
Officer· EVP, Chief Development Officer
Since Mar 2026
-5.10K
Net shares
Net seller
$48.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.10K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.10K
Price / share
$9.41
Trade value
$48K
% of position
5.1%
3/2/2026
99.43K→94.33K
Total
Net shares
−5.10K
Net value
-$48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | S · Sale | −5.10K | $9.41 | $48K | 5.1% | 99.43K | 94.33K |
| Total | −5.10K | -$48K | ||||||
Derivative Transactions0
No derivative transactions reported